KSS Antimicrobial Pharmacy Network Update Rakhee Patel December 2018

Meetings & Membership Inaugural meeting on 18/4/18 Meetings quarterly & chaired by Lead AMP, Dartford & Gravesham NHS Trust Membership - pharmacy representatives from acute hospital Trusts, community hospitals & primary care organisations including clinical commissioning groups Last meeting October 2018, next scheduled in January 2019

Benchmarking Benchmark around the AMR CQUIN/QP performance data (RAG rating) Collation of 18/19 data in progress quarterly Define® training deemed necessary to facilitate data capture – teleconference session December 18 Benchmark AMS service for member organisations via the network – survey monkey for secondary & primary care devised Updating and piloting a AMS Peer Review Inspection Tool in conjunction with PHE/NHSI

Antifungal stewardship All acute providers have shared antifungal guidelines with Specialised Commissioning Pharmacist Sharing antifungal audit toolkits amongst members & Specialised Commissioning Pharmacist Regional wide audit tool for the antifungal stewardship section of the medicines optimisation CQUIN devised

OPAT collaboration Benchmark exercise of OPAT service provision in network underway as part of survey Aim to share guidance, formulary applications, and device/stability information to improve uptake

Sharing resources NHS network site used for sharing useful resources to reduce duplication in work of AMS/ABX pharmacists across the region Facilitate peer review of guidelines and the sharing best practice The network is collaborating on producing maxillofacial/ENT antimicrobial guidelines

Quality Improvement project workstreams Sharing examples of good practice projects that are currently being undertaken, discussions on how to standardise across the region: 48-hour antimicrobial review on inpatient drug charts QI project To Dip or Not to Dip – Elizabeth Beech project Redesign of drug chart for 72 hour review Automatic stop at 72 hour if no review – prescription is stopped and the doctor contacted by a pharmacist or a nurse ARK study and principles Indications on outpatient prescriptions Electronic AMS development – Microguide DSM

Education, Training & Development RPS Local Professional Development Programme – EKHUFT Infection and AMS Face to Face Training Day on 26th September Supported by Lead AMP DGS & BSUH Next year to devise a rolling education & training timetable

Kent and Medway Infection Prevention and Control System Leadership Pilot Kent and Medway Infection Prevention and Control System Leadership National ambition to reduce Gram negative Blood Stream Infections (GNBSIs) by 50% by March 2021 More than half of these infections are in community setting Different approach to reduce these infections required compared to approach in reduction of infections such as Clostridium difficile and MRSA blood stream infections Gail Locock, Kent & Medway System DIPC

The role of the K&M System DIPC Be responsible to lead & develop IPC service across K&M system & produce a strategic plan with goals to achieve both local/national targets Provide strategic vision & leadership in the specialist field of IPC & provide expert knowledge/advice Lead on the development and innovation in IPC Raise awareness and actively promote IPC & AMS Work collaboratively/partnership with external agencies & other practitioners Ensure providers conform to agreed infection prevention quality measures

System Wide IPC and AMR Leadership / DIPC Role New role Seconded to the role from 22nd October IPC Specialist Nurse by background, previous Acting DIPC and Deputy at MTW Trust Creation of a virtual team of IPC leads and AMR pharmacist (TBC) Setting up of DIPC / DPH strategic meeting – Kent Infection Prevention & Control and Antimicrobial Stewardship (KIPCAS) Committee Medical engagement is required STP recognition

Prescribing review by Emma Cramp (QI advisor, GNBSI, NHSI) Aim: Highlight strengths and weaknesses within AMS programmes across the system Generate actions to take forward in order to improve AMS Reduce healthcare associated Gram negative bacteraemias & inappropriate prescribing Target: Members of IPC/AMS team Majority of data used from open access sources, such as PHE AMR Fingertips Portal and PrescQIPP

Any Questions?